Orion Office REIT Inc vs Veeva Systems — how do they compare? Orion Office REIT Inc trades at $2.55 (market cap $151.74M), while Veeva Systems trades at $260.88 (market cap $42.88B). The key difference: Veeva Systems is far larger — about 282.6× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 3.01% dividend while Veeva Systems pays none. Which is the better fit depends on your goals.
| ONL | VEEV | |
|---|---|---|
Market Cap | $151.74M | $42.88B |
Sector | Real Estate | Technology |
52-Week High | $3.00 | $306.22 |
52-Week Low | $1.93 | $151.43 |
Enterprise Value | $568.67M | $35.79B |
Dividend Yield | 3.01% | — |
Signals from Pluang's Aura AI — not financial advice
Orion Office REIT (ONL) trades at $2.66, down 1.85% on the day, with a bearish technical outlook and mixed fundamentals. The company reported a Q2 2026 earnings beat but continues to post significant net losses, with a negative net income margin of -65.66% in 2025. Despite a low price-to-book ratio of 0.24, indicating potential undervaluation, declining revenues and negative profitability metrics highlight ongoing challenges in its office property portfolio.
The outlook remains cautious due to persistent operational losses and high debt levels, though analyst sentiment is split evenly between Buy and Hold. Key risks include further revenue erosion and interest expense pressures, while potential catalysts hinge on successful portfolio repositioning and stabilized office demand as highlighted in recent earnings calls.
No Aura AI signal available yet.
Trailing returns across standard periods
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →